| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2357 |
Injection, omalizumab, 5 mg |
3,145 |
1,863 |
$1.21M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,093 |
3,637 |
$237K |
| J0517 |
Injection, benralizumab, 1 mg |
81 |
80 |
$213K |
| 96401 |
|
1,844 |
1,354 |
$135K |
| 99233 |
Prolong inpt eval add15 m |
1,442 |
482 |
$74K |
| 99223 |
Prolong inpt eval add15 m |
657 |
594 |
$60K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,429 |
1,311 |
$55K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,976 |
2,249 |
$19K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
424 |
204 |
$16K |
| 94060 |
|
407 |
405 |
$9K |
| 94729 |
|
320 |
319 |
$7K |
| 94726 |
|
192 |
191 |
$5K |
| 99406 |
|
610 |
560 |
$4K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
12 |
12 |
$4K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
707 |
575 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
26 |
26 |
$2K |
| 99215 |
Prolong outpt/office vis |
13 |
12 |
$732.78 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
34 |
14 |
$719.07 |
| 99443 |
|
29 |
25 |
$496.76 |
| 94727 |
|
14 |
14 |
$371.59 |
| 95012 |
|
24 |
24 |
$258.49 |
| 88740 |
|
31 |
26 |
$163.35 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
51 |
45 |
$63.65 |